Skip to main content
Figure 2 | World Allergy Organization Journal

Figure 2

From: Anti-Immunoglobulin E Therapy

Figure 2

Omalizumab structure. Omalizumab is a recombinyant humanized monoclonal antibody composed of 95% human sequence and 5% murine sequence. *CDR indicates complementarity-determining region. Adapted from Boushey [3].

Back to article page

World Allergy Organization Journal

ISSN: 1939-4551

Contact us